The U.S. Food and Drug Administration has approved for marketing a breathing tube coated with silver to be used by patients on ventilators.
FDA officials said the thin silver coating is known to have antimicrobial properties, thereby reducing the risk that patients on ventilators will acquire pneumonia while in the hospital.
The Agento endotracheal tube is intended for patients who must rely on a ventilator to breathe for 24 hours or more. Such patients are at risk of exposure to hospital-acquired bacteria that can accumulate on the tube or pass through the tube into their lungs, eventually causing a lung infection known as ventilator-associated pneumonia, the FDA said.
Fifteen percent of the patients on ventilators develop VAP every year and 26,000 die from the infection, according to the Centers for Disease Control and Prevention.
The device is manufactured by C.R. Bard Inc. of Murray Hill, N.J.
Copyright 2007 by United Press International
Related stories:
Silver-coated endotracheal tube dramatically reduces resistant infections
A silver-coated endotracheal tube may reduce infections with highly resistant bacteria over traditional tubes by nearly half, according to the results of a large randomized trial to be presented at the American Thoracic Society’s 2008 International Conference in Toronto on Monday, May 19.
Gene chips used to distinguish ventilator-associated pneumonia from underlying critical illness
Critically ill patients who need a ventilator to breathe face a high risk of pneumonia. The lung infection, however, is exceedingly difficult to diagnose because a patient's underlying condition often skews laboratory test results and masks pneumonia's symptoms – a reality that can delay appropriate antibiotic treatment.
Study sheds light on causes of HIV dementia
A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications. The finding, published in
Journal of Neuroscience, highlights a new target for drugs that could prevent HIV-associated dementia, an incurable and increasingly common complication in people with AIDS. Even with anti-retroviral drug therapies, up to one-half of people infected with HIV will develop mild to moderate neurological complications, according to some estimates.
Study supports value of advanced CT scans to check for clogged arteries
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
An emergency brake in the brain
Brain researchers at the University of Oslo in Norway have penetrated deeply into the innermost secrets of the brain to find out how brain cells can survive a stroke. Strokes are usually caused by occlusion of one of the blood vessels in the brain. When blood is prevented from supplying vital oxygen and energy to the brain cells, their electrochemical balance is upset, and they cause damage to themselves and to the surrounding brain cells before they collapse and die. Often this affects the memory centre, the hippocampus, where the cells are particularly vulnerable.
Inherited genetic cause, possible treatment found for complex lung disorder
A tale of two sisters has helped researchers solve a medical mystery and discover a familial genetic mutation that causes an inherited form of the lung disease Pulmonary Alveolar Proteinosis (PAP).
Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding
A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding. However, capsule-directed DBE (which is when the findings from an initial small bowel capsule endoscopy exam are used to guide the DBE procedure) may be preferred as the initial test due to the potential for fewer complications and decreased utilization of endoscopic resources. The study appears in the November issue of
GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).
Adult stem cell breakthrough
(PhysOrg.com) -- The first tissue-engineered trachea (windpipe), utilising the patient's own stem cells, has been successfully transplanted into a young woman with a failing airway. The bioengineered trachea immediately provided the patient with a normally functioning airway, thereby saving her life.